Marcus & Millichap Inc

MMI remains in a Stage 2 advance with a clear HH/HL structure and volume supporting up legs, but has recently pulled back, rejecting the 9 EMA and 21 EMA. The decline is testing the rising 50-day SMA and prior support zone. Execution is deferred to allow for acceptance at the 50-day average before committing to the bullish trend, avoiding action while price remains below the short-term EMAs.

• ↑Q1 2026 revenue reached $171.5M, up 18% YoY, strongest first quarter in four years.
• ↑Cash position of $335M with zero debt funded $23M in share repurchases.
• ↓Q1 net loss of $3M ($0.08/share) highlights ongoing profitability challenges.